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_______________________________________________________________________________________  
Background: Mutations of α-dystroglycan cause 
neuromuscular disorders known as primary 
dystroglycanopathies. 
Results: The high-resolution crystal structure of 
the T190M mutant of the N-terminal domain of α-
dystroglycan has been determined suggesting a 
decreased structural flexibility. 
Conclusion: The lower flexibility may account 
for the reduced glycosylation observed in T190M 
α-dystroglycan. 
Significance: The novel structural details suggest 
a molecular mechanism behind a severe form of 
muscular dystrophy. 
ABSTRACT  
      The severe dystroglycanopathy known as 
limb girdle disease is an autosomal recessive 
muscular dystrophy caused by the point 
mutation T192M in α-dystroglycan. Functional 
expression analysis in vitro and in vivo 
indicated that the mutation was responsible for 
a decrease in posttranslational glycosylation of 
dystroglycan, eventually interfering with its 
extracellular-matrix receptor function and 
laminin binding in skeletal muscle and brain. 
The X-ray crystal structure of the missense 
variant T190M of the murine N-terminal 
domain of α-dystroglycan (50-313) has been 
determined and showed an overall topology 
(Ig-like domain followed by a basket-shaped 




domain reminiscent of the small subunit 
ribosomal protein S6) almost identical to that 
of the wild-type structure. An extended and 
highly flexible loop (encompassing residues 
159-180) that could not be solved in the wild-
type N-terminal domain could, in part, be 
traced in the T190M variant. The 
crystallographic analysis prompts to a solvent 
shells reorganization around Met190 that 
affects the interaction between the B1-B5 anti-
parallel strands forming part of the floor of the 
basket-shaped domain, with likely 
repercussions on the folding stability of the 
protein domain(s) and on the overall molecular 
flexibility. Chemical denaturation and limited 
proteolysis experiments revealed a slightly 
decreased stability of the T190M variant with 
respect to its wild-type counterpart. This 
mutation may render the entire L-shaped 
protein architecture less flexible. The overall 
reduced flexibility and stability may affect the 
functional properties of α-dystroglycan via 
negatively influencing its binding behavior to 
factors needed for dystroglycan maturation, 
and may lay the molecular basis of the T190M-
driven primary dystroglycanopathy. 
________________________________________  
      The dystroglycan (DG) complex is composed 
of two subunits, α and β, that are formed from a 
unique precursor which undergoes a proteolytic 
event within the endoplasmic reticulum during the 
first steps of its maturation pathway (1,2). DG 
represents a widely expressed adhesion complex 
that plays a crucial role in offering stability to 
tissues being at the crossroad between 
cytoskeleton, plasma membrane and the 
surrounding extracellular matrix (3,4).  The DG 
main role is to bind with high-affinity laminins 
that are central organizers of the molecular 
network behind specialized basement membranes 
surrounding skeletal muscle. Besides, DG may 
form a plethora of additional interactions with 
other binding partners sharing laminin globular 
(LG) domains within epithelia, endothelia and 
Schwann cells. Indeed, its binding affinity may 
largely vary based on the degree of glycosylation 
of its α subunit (5).  
      DG has been particularly studied within 
skeletal muscle, a tissue where its α-subunit is 
found to be highly glycosylated, since a number 
of neuromuscular diseases involving 
glycosyltransferases active in muscle have been 
identified during the last years (6). The commonly 
accepted molecular scenario implies that 
hypoglycosylated DG cannot bind the skeletal 
muscle laminin-2 (7) with the usual high affinity, 
which would lead to the reduction of sarcolemma 
stability at the basis of a wide number of severe, 
or later onset, muscular dystrophies, defined as 
secondary dystroglycanopathies (6). 
      The α-subunit plays multiple important roles 
in DG, in that i) it is crucially involved in the 
maturation and posttranslational modification of 
the precursor; ii) it is highly modified with sugar 
chains especially in its central region (i.e. the 
mucin-like portion) from where some essential 
sugar moieties protrudes to bind laminin. The first 
is based on the noncovalent binding activity of α-
DG toward β-DG (8) while for the latter, it seems 
that the N-terminal domain may be central in 
recognizing and directing the activity of important 
modifying enzymes, such as the like-
acetylglucosaminyltransferase (LARGE) that adds 
the repeating disaccharide block [-α3-glucuronic 
acid (GlcA)-β3-xylose (Xyl)-] required for 
laminin-binding (9) to a phosphorylated mannose 
of α-DG (10).  
      We have pioneered studies on α-DG at the 
molecular level (11) having extensively 
characterized the structure of the N-terminal 
domain of α-DG which is shaped in two 
subdomains (12). The first is a typical Ig-like 
domain, while the second one is similar to the S6 
protein present in the small ribosomal subunit of 
T. termophilus (13).   
      Although a plethora of interesting studies are 
currently unraveling the structure of the sugar 
blocks modifying the mucin-like domain of α-DG 
as well as the exact residues of α-DG involved in 
these modifications (14-17), no ultimate structural 
information is currently available on the 
dystroglycan/laminin complex at the molecular 
level. The challenges in obtaining crystals of the 
complex mainly arise from the highly 
heterogeneous nature of α-DG glycosylation, 




confirmed by the fact that the protein can be 
typically visualized in overlay assays or Western 
blots as a band with a broad smear appearance 
indicating a distribution of different molecular 
masses (1,3,4). In addition, the molecular 
mechanism behind the first case of primary 
dystroglycanopathy caused by the first disease-
causing missense mutation found in a Turkish 
family in homozygous fashion (18) has yet to be 
clarified. Interestingly, the human T192M 
mutation (and its topological counterpart in 
mouse, T190M), lies within the strand B1 that 
together with the strands B2, B3, B4 and B5, 
arranged in an anti-parallel topology, defines the 
floor of the basket shaped S6-like domain (13). 
Theoretically, the Thr to Met semiconservative 
mutation is unlikely to cause per se a high degree 
of disorder/instability, and it should not represent 
a site of O-glycosylation.  
      Nonetheless, we believe that the structural 
analysis of the T190M mutant of α-dystroglycan 
is a fundamental step towards the understanding at 
the molecular level of the mechanism leading to 
muscular dystrophy. Following this basic idea, we 
expressed the murine mutant in our recombinant 
expression system in E.coli and purified it for 
crystallization studies aimed at possibly solving 
its structure and comparing it with that of the 
wild-type protein previously reported (13).      
 
EXPERIMENTAL PROCEDURES 
       Mutagenesis and Primers-  The murine α-
DG(50-313)R166H (hereinafter WT) DNA was 
cloned into a bacterial vector, pHis-Trx, for the 
expression of the protein as thioredoxin fusion 
product, also containing an N-terminal 6xHis tag 
and a thrombin cleavage site, as previously 
described (13). The point mutation T190M was 
introduced into the WT DNA construct using the 
QuikChange site-directed mutagenesis kit 
(Stratagene) and appropriate primers. Briefly, the 
mutation was inserted within the coding region of 
the WT N-terminal domain cloned in the vector 
pHis-Trx (13) for prokaryotic expression aimed at 
crystallographic analysis, and within the entire 
cDNA sequence of the murine DG cloned in the 
pEGFP-N1 plasmid for expression in eukaryotic 








     The construct DGT190M-pEGFP-N1 allows to 
express dystroglycan with a Green Fluorescent 
Protein (GFP) fused at the C-terminus of β-DG. 
Moreover, a myc tag is present, inserted after 
Lys498, within the C-terminal domain of α-DG 
(19). All constructs were verified by automated 
sequencing. 
      Fusion protein expression and purification- 
The recombinant α-DG(50-313)R166H T190M 
(hereinafter T190M) fusion protein was expressed 
in Escherichia coli BL21(DE3) Codon Plus RIL 
strain and purified using nickel affinity 
chromatography. The fragment of interest was 
obtained upon thrombin cleavage. Further 
purification steps were carried out using anion 
exchange and gel filtration chromatography. 
Namely, after thrombin cleavage, the flow 
through of a HiTrap Chelating column (GE 
Healthcare) was applied onto a Hi-Trap Q HP 
column (GE Healthcare) pre-equilibrated with 
buffer A (25 mM Tris–HCl pH 7.5). T190M was 
eluted with a linear gradient of 0-0.5 M NaCl in 
buffer A. The fractions containing T190M were 
pooled, concentrated with Amicon Ultra 15 
(Millipore) and loaded on Superdex 200 10/300 
GL (GE Healthcare) pre-equilibrated with 25 mM 
Tris–HCl pH 7.5, 0.15M NaCl, at a flow rate of 
0.4 mL/min: the core fractions of the peak were 
supplemented with 2.5% Glycerol and 
concentrated by Microcon GM10 (Millipore). The 
purity of the protein was confirmed by 
Tricine/SDS-PAGE (20). 
      The possibility that the methyl sulfide 
(thioether) of Met 190 would be oxidized in 
T190M, or in general that the recombinant peptide 
would harbour some additional undesired 
modifications, has been ruled out via mass 
spectrometry analysis exploiting an Orbitrap 
instrument (Thermo Scientific) (data not shown). 
The corresponding mass value obtained also 
confirmed the presence of a disulfide bridge 




between Cys180 and Cys262.   
      Crystallization, data collection, structure 
solution and refinement- Crystals of T190M were 
grown by using the vapor diffusion hanging drop 
method, following the protocol used for WT (13). 
Drops were prepared by mixing 1 µL of the 
protein solution (5.25 mg/mL in 25 mM Tris, 150 
mM NaCl and 2.5 % glycerol; pH 7.5) with 1 µL 
of the precipitant solution (0.8 M citrate buffer;  
pH 7.0) and equilibrated against the reservoir (1 
mL) at 4 °C.  
     Data collection was carried out at the European 
Synchrotron Radiation Facility Grenoble (France) 
at the ID23-1 beamline, using a detector Pilatus-
6M (Dectris) and the wavelength of 1.00 Å. Data 
collection was carried out at -173 °C. Before 
being exposed to the X-ray beam, crystals were 
quickly dipped in cryoprotectant solution (25% 
ethylene glycol, 1.0 M citrate buffer, pH 7.0) and 
flash frozen in liquid nitrogen.  
      Indexing, integration and data reduction of the 
diffraction data were carried out by using a 
combination of XDS (21) and CCP4 (22) 
programs. Data reduction statistics are reported in 
Table I.  
      The structure solution of T190M was obtained 
by Patterson search methods with PHASER (23) 
using the crystal structure of WT as template 
(PDB id: 1U2C). Restrained refinement of the 
crystal structure was carried out by using 
phenix.refine (24). The improvement of the initial 
model underwent a protocol that included a rigid 
body fitting stage followed by simulated 
annealing, coordinates and individual B-factors 
refinement. The subsequent stages integrated a 
Translation-Libration-Screw (TLS) model 
parameterization before the individual B-factors 
refinement. Automatic refinement cycles were 
alternated with manual rebuilding sessions 
performed with COOT (25). Solvent molecules 
were identified by the automatic water-picking 
algorithm implemented in phenix.refine (24). The 
overall quality of these automatically picked 
solvent molecules were manually checked. 
Multiple conformations were introduced for 
selected side chains during the last cycles of 
refinement.  
      Protein stereochemistry was monitored 
throughout the refinement process and during 
manual rebuilding with MolProbity (26). Statistics 
of the crystallographic refinement are reported in 
Table I. 
      Protein structures superposition was carried 
out using ProFit (Martin, A.C.R., 
http://www.bioinf.org.uk/software/profit/). The 
STRIDE web-server was used to assign the 
protein secondary structure (27). Interfaces 
between domains, solvent accessible areas and  
solvation energies were analyzed by using PISA 
as part of the CCP4 package (28). Water-protein 
interactions was analyzed using the WAP web-
server (29). 
      Coordinates and structure factors have been 
deposited in the PDB, with accession code:  
4WQI. Figures were prepared using PyMol (30). 
      Fluorescence analysis- Equilibrium 
fluorescence titrations were performed in 50 mM 
Tris HCl, pH 7.4, with spectra collected at each 
GdnHCl concentration (point by point, as to avoid 
photo-bleaching phenomena) at 25 °C in a 1-cm 
quartz cuvette using a fluorescence 
spectrophotometer Cary Eclipse (Agilent 
Technologies). The final concentration of protein 
(both WT and T190M) was 0.1 µM, and for each 
point spectra were taken after 20 minutes of 
equilibration time (31). The excitation wavelength 
was 280 nm, and emission spectra were recorded 
between 300 and 400 nm. The fluorescence peak 
change as a function of guanidine concentration 
was fitted to the following phenomenological 
equation, that allowed to calculate the Gdn50% of 
the transition: 
 






where c represents the guanidine concentration at 
the midpoint of the curve (Gdn50%), and a, b and d 
are fitting parameters, with d denoting the slope of 
the curve; calculations were carried out using the 
Kaleidagraph software. All the reagents used were 
of high purity grade from Sigma.     




      Limited proteolysis- WT and T190M at 30 µM 
in 50 mM Tris (pH 8) buffer were subjected to 
limited proteolysis at 37 °C by the addition of 
trypsin (Sigma) to a final concentration of 2 
µg/mL. The reaction was stopped after 1, 5, 10, 
20, 40 and 60 min by adding SDS sample buffer 
to aliquots of the reaction mixture. The samples 
were analyzed by performing 15% Acrylamide 
SDS-PAGE and Coomassie staining. As a control 
the same time course was performed in the 
absence of the enzyme. 
SuperResolution Microscopy with 3D 
SIM- Human osteosarcoma U2OS cells cultured in 
DMEM, 10% FBS, were seeded on #1.5H 
precision cover glass (Marienfeld-Superior). The 
cells were transfected with the corresponding 
pEGFP-N1 vectors expressing fusions to WT and 
T190M with polyethylenimine (PEI) precipitates 
based on a 3:1 ratio of PEI (µg) to total DNA 
(µg).  48h post transfection the cells were fixed in 
4%PFA. Lipid staining was achieved after 30min 
incubation in a 1:2000 dilution of Cellmask 
Plasma Membrane Orange dye (Invitrogen). The 
cover glass was mounted in Vectashield 
containing DAPI (Vector Laboratories) for 
nuclear counter stain and sealed with nail polish. 
U2OS cells expressing WT-EGFP and T190M-
EGFP were imaged on a 3D Structured 
Illumination Microscope (3D-SIM) OMX v.4 (GE 
Healthcare). The refraction index of the 
immersion oil was chosen to avoid spherical 
aberrations in the green emission channel. DAPI 
was excited with a 405 nm, EGFP with 488 nm 
and Cellmask Plasma Membrane Orange with 568 
nm laser while sCMOS cameras recorded the 
corresponding emission in the following 
bandwidth of 436/31 nm, 528/48 nm and 609/37 
nm. The 3D structured illumination images were 
reconstructed in the Softworx v6.1.1. software 
(GE Healthcare) at a wiener filter setting of 0.004 
and using one week old recorded OTFs optimized 
for the 528 nm emission channel. For presentation 
here, the final images were adjusted linearly in 
intensities with the software package Fiji (32) to 
minimize any visible spherical aberrations in the 
blue and red emission channels. Raw data is 
available upon request. 
 
RESULTS   
      Crystallization and crystal structure 
determination- Well shaped crystals of T190M 
grew in 7-10 days as regular slabs that diffracted 
X-rays.   
The crystal structure of T190M has been 
determined and refined up to a resolution of 1.6 
Å. The final model includes residues in the ranges 
58-163 and 179-303 which could be traced in the 
2Fo-Fc electron density map. The overall structure 
of T190M does not show remarkable differences 
with respect to WT. The RMSD between the 
T190M and WT structures is 0.758 Å (calculated 
on 268 Cα) which decreases to 0.297 Å when 
omitting from the RMSD calculation the 4 
residues (157-160) being part of the flexible loop 
discussed in the next paragraph. As reported for 
WT (13), the structure of T190M consists of two 
domains, (Fig.1): the first one described as an Ig-
like domain (residues 60-158) and the second one 
(residues 180-313) similar to the small subunit 
ribosomal protein S6. The spatial organization of 
the domains is conserved in the T190M crystal 
structure as well as the interaction surfaces 
between the two domains. A flexible loop, which 
links together the two domains, could be traced 
only at the N-terminal side (residues 159-163: 
His-Asn-Glu-Pro-Gln).  It should be noted that the 
WT structure refers anyway to a protein carrying 
the additional single mutation R166H that was 
originally introduced to stabilize the recombinant 
protein during purification (13). The same 
mutation is also present in T190M, although this 
position falls into the region of the flexible loop 
that could not be traced either in WT or in T190M 
(see below). 
    The crystallographic analysis confirmed the 
substitution of Thr190 with Met, as showed in 
Fig.2 and, according to the refined model, the 
T190M mutation does not introduce significant 
conformational changes in the nearby residues. 
These findings altogether indicate that this 
mutation does not significantly alter the (either 
overall or local) structure of T190M with respect 
to that of WT. 
     Despite showing almost identical crystal 
structures, WT and T190M differ in the 
conformation of the flexible loop linking the two 




domains (residues 159-179). Indeed the 
conformation of the residues 158-163 in T190M, 
that has been best modeled based on the Fourier 
maps (Fig.3) and by monitoring the Rfree, differs 
with respect to the one being observed for 
residues 158-160 in WT (PDB id: 1U2C). It is 
worthy of note that the Fourier maps pinpoint to at 
least two alternative main-chain loop 
conformations (Fig.3, Fig.S1). However, attempts 
to model the loop with a conformation as 
observed in the WT structure did not result in 
improvement of either the Fourier maps or of the 
Rfree, indicating that the WT conformation 
contributes with a rather low occupancy factor. 
The refined structure suggests that the ensemble 
of main-chain loop conformations has changed in 
T190M and that the most populated 
conformational state differs from that observed in 
WT. Moreover, in T190M the loop could be 
traced for three additional residues, up to Gln163, 
with respect to the WT structure, with residues 
158-161 assuming a β-Turn structure (Fig.3, 
Fig.S2). This observation supports a different 159-
179 loop organization in the T190M structure, at 
least in its N-terminal part. Furthermore, the better 
loop definition should not be merely taken as an 
effect of the higher resolution of the T190M 
crystal structure with respect to that of the WT 
(refined at 2.3 Å), since the backbone trace could 
not be extended in any of the other otherwise 
undefined regions of T190M such as the N- and 
C-terminal regions (residues 58 and 303) or the C-
terminal part of the flexible loop. Being the WT 
and the T190M crystallization conditions almost 
identical and the crystal structures exhibiting the 
same packing features, it is reasonable to correlate 
such observed differences to the Thr vs Met 
mutation at position 190, which would result in an 
increased proximity of the loop to the side chain 
of the mutated residue.  
     Residue 190 is located at the center of the B1 
β-strand, at the bottom of the basket-like domain 
and is solvent exposed (13). The point mutation 
Thr to Met does not seem to introduce any 
significant change in the local structure. The Met 
residue nicely superpose on the position occupied 
by Thr in the WT (Fig.2), with the Cβ-Cγ bond 
rotated by ≈ 20° with respect to the corresponding 
bond (Cβ-Cγ2) in Thr, while the Cγ-Sδ-Cε group 
is pointing towards the solvent region. 
Furthermore, in the T190M structure, the nearby 
residues geometries are not significantly affected 
by the point mutation.       
      Despite the limited effect of the Thr to Met 
mutation on the neighboring residues, the 
introduction of a bulkier and apolar group such as 
the methylthio group of the methionine causes a 
re-organization of the surrounding water 
molecules. An analysis made with PISA (28) 
shows that the solvent exposed surface is more 
than doubled when considering Thr in the WT (≈ 
13 Å2) and Met in the T190M mutant (≈ 34 Å2). 
Furthermore, the solvation energy contribution 
estimated by PISA for each residue in the 
crystallographic models goes from -0.01 
kcal/mole (Thr in WT) to 0.74 kcal/mole (Met in 
T190M), indicating a potentially perturbing effect 
of the methionine on the surrounding water 
molecules.  
      An analysis of the solvent structure in the 
crystallographic models shows that several waters 
surrounding residue 190 are conserved in WT and 
T190M. Their positions, although shifted by 0.4-
1.0 Å, display the same interactions network. 
Nonetheless, some differences in the solvent 
organization are actually evident (as shown in the 
two panels of Fig.4). Namely, WAT304 (WT, 
PDB_id: 1U2C) interacts with Thr190 OH in WT 
but it is absent in T190M (Fig 4a). The lack of 
WAT304 in T190M is rather interesting, as this 
water molecule bridges together the B1 and Β5 β-
strands by interacting with the backbone of 
residues Val188 (O) and His296 (O), and with the 
side chains of residues Thr190 (Oγ1) and His296 
(Nδ1). Moreover, solvent structure changes were 
also found in a region occupied in T190M by 
Asn160, whereas the same space is populated by 
solvent waters in WT (Fig. 4b). Indeed, Asn160, 
which is part of the flexible loop discussed above, 
protrudes from the loop towards Met190 and 
interacts through Oδ1 with a WAT660 water 
molecule (T190M, PDB_id: 4QWI), which in turn 
interacts with Oγ of Ser257 and with other solvent 
molecules. Such a water molecule is not present in 
the WT crystal structure.  
      It is quite apparent that the substitution of a 




hydrophilic residue such as threonine with a 
bulkier and apolar one like methionine results in a 
solvent re-organization around the residue itself. 
Changes in the structure solvation sphere may 
have significant consequences on the overall 
stability of the protein domains or in locally 
altering the conformational ensemble distribution 
of the 159-179 loop, that in turn may also affect 
the reciprocal orientation of the two domains. 
      Stability measurements- Chemical unfolding 
experiments have been performed in order to 
establish the relative stabilities of WT and T190M 
in solution. Fluorescence emission has been used 
as a mean to record the exposure of the aromatic 
residues (mainly Trp) to the solvent, with 
emission maxima that range from ≈ 310 nm of the 
fully buried to ≈ 350 nm of the fully exposed 
tryptophan residues (33). The four tryptophan 
residues in the WT primary sequence are good 
fluorescent probes of the unfolding behavior of 
the domain and its mutant upon addition of a 
chemical denaturant such as Guanidine 
Hydrochloride (GdnHCl). Fig.5A shows the 
unfolding curves of WT and T190M as a function 
of GdnHCl concentration. In the absence of 
denaturant, the emission spectra of both WT and 
T190M are those of native-like proteins, with 
peaks in the spectral region of buried tryptophan 
residues; the fact that the mutant’s peak is slightly 
red-shifted as compared to the wild-type might 
reflect an increased exposure of the mutant to the 
solvent. The plot of the emission spectra peaks as 
a function of GdnHCl reveals a cooperative 
unfolding behaviour for both WT and T190M, 
with transition midpoints (Gdn50%, i.e. the 
denaturant concentration inducing 50% of the 
total peak shift) of 1.45M and 1M, respectively, 
indicating that WT is slightly more stable than 
T190M.  
      To gain further insights into the stability of the 
two variants of α-DG, limited proteolysis 
experiments have been performed. Both variants 
contain 19 predicted potential sites for trypsin 
cleavage (Peptide cutter tool at 
http://web.expasy.org) and therefore are likely to 
be completely degraded following trypsin 
digestion. T190M was rapidly cleaved by trypsin 
and completely degraded within 10 minutes of 
digestion. WT instead was less susceptible to 
tryptic cleavage and showed a clear degradation 
only after 40 minutes of digestion (Fig. 5B) but 
was still present after 1 hour of digestion. 
Considering that neither of the two variants is 
subjected to degradation in the absence of the 
protease in the same experimental conditions (data 
not shown), T190M is clearly more susceptible to 
proteolysis than WT, confirming the latter to be 
more stable, in accordance with the results of the 
chemical denaturation experiments.     
            SuperResolution Microscopy- The 
Osteoclast cell line U2OS has been tranfected 
both with the EGFP plasmids carrying the WT 
and T190M full-length dystroglycan variants (19), 
respectively and the cells have been analyzed by 
3D structured illumination microscopy on an 
OMX v.4 system..              
       No relevant differences have been observed 
between WT (Fig. 6A) and T190M (Fig. 6B). In 
both variants, α-DG undergoes its maturation 
cycle and it is extensively trafficked via the 
endoplasmic reticulum to the plasma membrane 
where it is nicely localized to filopodia and also to 
podosomes located at the cell periphery, 
suggesting no dramatic alterations as far as the 
distribution of α-dystroglycan/β-dystroglycan is 
concerned.      
 
DISCUSSION  
     According to the high resolution X-ray crystal 
structure here presented, the overall structure of 
the N-terminal domain of α-DG is not 
significantly affected by the T190M mutation, nor 
remarkable local conformational changes of the 
residues close to position 190 have been detected. 
At large, this finding seems to be fully supported 
by the fluorescence microscopy analysis, that does 
not record dramatic differences in the phenotype 
of T190M transfected osteoclasts with respect to 
their WT counterpart. The outcome of the 
fluorescence microscopy experiments (showing 
that at least β-dystroglycan has a typical 
localization pattern in T190M) is definitely 
indicating that the mutation is acting in quite a 
subtle and intriguing molecular regulatory 
fashion, or anyway that its effect would be much 




less observable in an isolated cellular context than 
in skeletal muscle fibres (18). 
     The major effect of the T190M mutation seems 
to be related to the disruption by the bulkier and 
apolar methionine side chain of the surrounding 
solvent network structure. Indeed, it is well 
known that solvation may play a critical role on 
the stability and the conformational equilibrium of 
a macromolecule  (34), as well as on the protein-
ligands interactions (35). Furthermore, it has been 
reported that a single mutation, even at the surface 
of a protein, can affect the folding/unfolding free 
energies as a result of altering the solvent 
organization (36). In T190M the differences 
observed in the solvent organization around 
Met190 may account for the structural and 
thermodynamic differences observed with respect 
to WT. Indeed, T190M resolves in the formation 
of a new hydrogen bonding network involving 
Asn160 and the water molecule WAT660, which 
may influence the flexibility of the 159-179 loop. 
Moreover, the loss of stabilizing interactions 
between the B1 and B5 β-strands due to the 
absence of WT WAT304, may account for the 
T190M lower stability revealed by the chemical 
denaturation and limited proteolysis experiments 
(see below). 
      Indeed, a particularly interesting aspect seems 
to be that in this case we have been able to trace 
part of the flexible loop (encompassing residues 
160-180) that in the WT domain was even less 
structured, due to its high mobility and flexibility 
(13). Such a result may imply that the Thr to Met 
mutation has interesting consequences for the 
structural dynamics of the entire N-terminal 
domain. The enhanced rigidity of T190M may 
affect the overall dynamics and orientation of the 
two subdomains within the L-shaped α-DG 
molecular architecture, eventually influencing its 
global conformation and its function. 
      This possibility seems to be corroborated by 
the evidence that in solution T190M has a lower 
stability than the WT, as suggested by the 
different melting points calculated on their 
unfolding curves. Although the T190M 
denaturation curve has a melting point at about 1 
M GdnHCl, denoting a rather stable protein, the 
decrease in stability with respect to WT is small 
but significant, as further confirmed by limited 
proteolysis experiments. 
      The exact molecular mechanism leading to 
hypoglycosylation of α-DG carrying the T190M 
(T192M in human) mutation and causing a severe 
dystrophic phenotype, accompanied by some 
degree of intellectual impairment, is currently 
unknown (18). Via co-immunoprecipitation 
experiments, it was shown by Hara and colleagues 
that the mutated N-terminal domain of α-DG is 
likely to exhibit a reduced affinity towards 
LARGE, that is responsible for adding a repeating 
disaccharide unit [-α3-GlcA-β3-Xyl-], that is 
thought to be crucial for extracellular matrix 
protein binding, to O-mannosylated α-DG (18). It 
is then possible that the T190M/T192M mutation 
is indeed provoking some degree of local 
perturbation that is affecting the conformation of 
the entire domain, or at least, of the two modular 
domains, influencing its binding to LARGE. 
      Kanagawa and colleagues have shown that the 
N-terminal domain of α-DG is shed by furin, in a 
process that is likely to take place into the 
intracellular Golgi compartments in which the 
final steps of the DG maturation process are 
completed (37). Based on a possible alternative 
chronological order dictating the chaotic 
molecular events taking place in the Golgi, in 
which the furin enzymatic step would anticipate 
LARGE binding to α-DG, it can be postulated 
that such an autonomous domain of α-DG (12) 
may represent not only a recognition substrate but 
also an (allosteric?) activator for LARGE (38).  
      Interestingly, following the findings of a 
recent computational docking study, it was 
hypothesized that the T190M/T192M mutation 
might affect directly the binding of α-DG to 
laminins (39). However, we believe that such a 
mechanism would be highly unlikely. Although 
we previously measured in the recombinant WT 
the presence of some residual binding activity 
towards laminin-1 (13), such an activity was 
displaying itself at a much lower affinity than that 
observed for full-length and glycosylated native 
α-DG binding to laminin and agrin (5,11,40). In 
addition, such residual binding activity was 
apparently harboured by the first Ig-like domain 
of α-dystroglycan and not by the S6-like domain 




where the T190M/T192M mutations resides (13).      
      α-DG post-translational O-glycans decorations 
along the endoplasmatic reticulum and 
modifications accomplished in the Golgi, are 
crucial for its ability to function as an extracellular 
matrix (EM) receptor  and namely to bind to EM 
proteins such as laminin, perlecan, agrin and 
neurexin in the brain and pikachurin in the retina 
(5). Notably, the same are required for the binding 
of α-DG to Old World arenaviruses (16). 
Recently, a β-1,4-glucuronyltransferase, 
designated B4GAT1, has been also identified to 
be involved in the initiation of the LARGE-
dependent enzymatic process (41,42). 
      Although a few glycosylation sites have been 
proposed and/or localized within the N-terminal 
and C-terminal domains of α-DG, most of the O-
linked oligosaccharide chains protrude from Thr 
and Ser residues placed within its central mucin-
like domain (2,43,44). A thorough biophysical 
characterization of the “naked” mucin-like 
domain of α-DG clearly pointed to the dramatic 
role played by the glycosylation in its 
conformational stability (45).  
     Recently, the unveiled structural basis for the 
recognition of an O-glycan, GalNAc-Neu5Ac, and 
its attached mucin-like peptide GPATPAP by the 
paired Ig-like type 2 receptor α (46) prompted us 
to envisage that the Ig-like modular architecture 
of the N-terminal α-DG region may also function 
as a protein “hub” for the recognition of the 
oligosaccharides protruding from the neighboring 
α-DG mucin-like domain. Furthermore, it may be 
a docking site for one of the two domains of the 
glycosyltransferase LARGE (47), belonging to the 
GT-8 and GT-49 families respectively (48). 
Possibly, in solution, the effect of the T190M 
mutation, being next to the flexible hinge 
connecting the two subdomains, may “propagate” 
to the Ig-like domain by changing its relative 
orientation with respect to the S6-like domain also 
influencing its binding properties. It is worthy of 
note that the presence of a second Ig-like domain 
within the C-terminal region of α-DG has been 
confirmed by bioinformatic analysis and 
molecular modeling; the domain has been 
biochemically characterized and shown to include 
the β-DG binding epitope (49).    
      Such interesting structural hypotheses, 
necessarily await further rounds of 
experimental/computational validations by means 
of techniques being able to explore the dynamical 
behaviour of α-DG (NMR, Molecular Dynamics). 
Furthermore, molecular modeling and docking 
tools will be exploited to investigate the 
likelihood of α-DG binding to LARGE or to other 
regulatory factors important for dystroglycan 
maturation. Our molecular analysis of the N-
terminal T190M variant of α-DG may pave the 
road to the elucidation of the molecular 
mechanism of a specific case of 
dystroglycanopathy, with important consequences 
for clinicians and for designing possible therapies, 
but in addition it may be also relevant from a 
cellular and molecular biology perspective, 
helping to improve the overall picture of the 
multiple structural aspects underlying the 
maturation and function of the dystroglycan 
complex.   
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FIGURE LEGENDS 
FIGURE 1. Cartoon depiction of the T190M crystal structure. The two domains are colored in violet (Ig-like 
domain) and yellow (small ribosomal S6 subunit domain), respectively; the B1 and B5 β-strands are labeled 
for clarity. Spheres representation is employed for highlighting Met190. The loop regions connecting the 
structural elements are shown for both WT (colored in cyan) and T190M (colored in red). 
 
FIGURE 2. Calculated σA-weighted 2Fo-Fc map (contoured at 1.0 σ and colored in light-blue) and the Fo-Fc 
map (contoured at  ± 3.0 σ and colored in green for positive values and in orange for negative values). The 
maps have been calculated following the Patterson search stage using the WT as a model (PDB id: 1U2C). 
The final model of T190M (colored in blue) is superposed to the initial Patterson search solution (colored in 
pink-salmon). Both models are represented as ribbon except residues at position 190 (Thr for the template 
structure and Met for the mutated final model), which are represented as sticks. 
 
FIGURE 3. SA-omit σA-weighted 2Fo-Fc  map (contoured at 1.0 σ and colored in grey) and the Fo-Fc  map 
(contoured at  3.0 σ and colored in green) overlaid with the loop region encompassing residues 156-163 as 
the T190M final model (PDB id 4WQI). Maps have been calculated using the T190M model, where residues 
156-163 have been omitted from the calculation. The loop nicely fits the 2Fo-Fc  map which is indicative of 
the electron density of the molecule. 
 
FIGURE 4. Details of the H-bond networks involving selected water molecules and residues. The structural 
elements of the N-terminal domain of α-DG are represented as ribbon; residues involved in the interaction 
networks are represented as sticks. A) H-bond network involving WAT304 in WT. Met 190 (T190M mutant) 
is superimposed to Thr190 (WT) for comparison, with the B1 and B5 β-strands labeled for clarity. B) H-
bond network in the mutated T190M involving WAT660. Interatomic distances are reported in Å.  
 
FIGURE 5. A. Equilibrium unfolding curves of WT and T190M. The red-shifts in the fluorescence peaks 
upon addition of GdnHCl indicate a progressive exposure of the tryptophan residues to the solvent: the data 




fit to a single cooperative transition for both WT, closed circles, and T190M , open circles, with a difference 
in midpoints (Gdn50%) of 0.45M, that reveals the mutant to be slightly less stable than the wild-type protein. 
Both experiments were performed in triplicate, and no significant deviation from the above curves was 
detected.  B. Limited proteolysis of WT and T190M. Tryptic digestion time course of the two variants.  
 
FIGURE 6. 3D Structured Illumination Microscopy images of U2OS cells expressing DG and DGT190M 
fused to EGFP. DG-EGFP (A) and DGT190M-EGFP (B) are both localized specifically at the plasma 
membrane and accumulate in the cytoplasm. The columns show the individual images for DAPI (blue), 
EGFP (green), Cellmask Plasma Membrane Orange (red) and the resulting RGB overlay. The first row of 
images is the z stack maximum intensity projection of the 3D recording of the cell. The two subsequent rows 
of images are at a specific z position in the stack (XY) and X position slice through the stack (XZ). The 
white bar represents 10µm.  
 
FIGURE S1. SA-omit σA-weighted 2Fo-Fc  map (contoured at 1.0 σ and colored in light-grey) and the Fo-Fc  
map (contoured at  3.0 σ and colored in dark-grey)  overlaid with the loop region encompassing residues 
156-160 as in the WT model (PDB id 1U2C). Maps have been calculated by using the T190M model where 
residues 156-163 have been omitted from the calculation. 
 
FIGURE S2. Detail of the superimposition of the WT and T190M mutant. The models are represented as 
ribbons, with WT colored in black and T190M colored in light-grey; Met 190 is depicted as a ball-and-stick 
model. The superimposition of the two crystal structures emphasize the different conformations of the 











TABLE I: X-ray diffraction: data collection and model refinement statistics 
Data Collection  
Space group          H 3  
Unit-cell parameters (Å)                                a=71.879, c=144.296 
Molecules per asymmetric unit                              1 
Wavelength (Å)        1.00 
Resolution (Å)        48.1 – 1.59  (1.65 – 1.59)a 
Total observations        119373 
Unique reflections        35504 
Rmerge (%)b       4.3 (44.2) 
<I/ σ (I)>         15.28 (1.74) 
Completeness (%)        95.0 (71.8) 
Redundancy         3.4  (2.3) 
 
Refinement  
Number of reflections (work-set/test-set)   33720/ 1784 
Rworkc/ Rfreed (%)       14.61 / 16.32 
Number  of non-H atoms        
 Protein       1741 
 Waters       194 
 Organic (ethylene glycol)    12 
 Ions (Cl-)      1 
Average isotropic B factors (Å2)      32.9 
 Protein (main chain)       28.9 
 Protein (side chain)       35.8 
 Solvents        39.1 
r.m.s. deviation 
  Bond length (Å)       0.010 
 Angle (deg)        1.245 
Ramachandran plot  
 favored regions (%)       100 
 allowed regions (%)       0 
 disallowed regions (%)      0 
_________________________________________________________________________________________________________________________________________ 
a Values in parenthesis are given for the highest resolution shell  
b Rmerge = ∑hkl∑j│Ihkl ,j-<Ihkl>│/ ∑hkl∑j Ihkl ,j  
c Rwork = ∑work-set│Fobs-Fcal│/ ∑work-set Fobs;  
d Rfree = ∑test-set |Fobs-Fcal|/ ∑test-set Fobs 
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